Dr. Mir-Farzin Mashreghi

Since 2023rnDeputy Scientific Director at DRFZ (since May 2023)rnrnSince 2022rnHead of the third Research Area “Systems Rheumatology” at the DRFZ (November 2022)rnrn2020-2022rnGroup Leader of the joint DRFZ/BIH Center for Regenerative Therapies (B-CRT) “Single-Cell-Laboratory for Advanced Cellular Therapies”.rnrnSince 2018rnScientific Head “Next Generation Sequencing”, Leader of the Laboratory of Molecular Rheumatology “Regine von Ramin Labor” at the DRFZ.rnrnSince 2016rnGroup Leader “Therapeutic Gene Regulation”, Programme Area III: Regenerative Rheumatology at the DRFZ Berlin.rnrn2007 –2016rnResearch Associate at the Cell Biology department (Head: Prof. Dr. Andreas Radbruch) at the DRFZ Berlin.

2024rnFachimmunologe der Deutschen Gesellschaft für Immunologie (DGFI)rnrn2003 –2007rnPhD thesis at the Charité Universitätsmedizin Berlin, Institute of Medical Immunology, Supervisors: Prof. Dr. H.-D. Volk / Prof. Dr. P.-M. Kloetzel; “Functional analysis of the transcription factor STAT3 regulated by the induction of the cytoprotective enzyme heme oxygenase-1”, magna cum laudernrn2002 –2003rnDiploma thesis at the Charité Universitätsmedizin Berlin, Institute of Medical Immunology, Supervisor, Prof. Dr. H.-D. Volk; “Strategies for the diagnosis of subclinical and clinical acute rejection episodes in renal transplantation”rnrn1998 –2003rnUniversity studies at the Freie Universität Berlin, Department of Biology, Pharmacy und Chemistry, Field: Biochemistry diploma, Subjects: Biochemistry, Biophysics, Immunology, Biology, Organic Chemistry, Physical Chemistry and Physics. Mark: Excellent

Since 2023rnDRFZ Lead PI, Area “Immunity, Inflammation and Infection” of the „Deutsches Zentrum für Kinder und Jugendgesundheit“, Berlin Locationrnrn2018-2023rnStudy Group Coordinator of EFIS-IL-Study Group “Non-coding RNA and epigenetic regulation in immune cells”

u003cp class=u0022CV01Introductionu0022u003eDeutsche Gesellschaft für Immunologie (DGFI)u003c/pu003e

Wolfgang Schulze Award 2011, „Therapeutic use of microRNAs in rheumatology“